| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
143,541 |
132,449 |
$13.80M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
70,667 |
61,398 |
$4.51M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
33,724 |
31,953 |
$3.25M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
7,959 |
7,148 |
$1.57M |
| 80053 |
Comprehensive metabolic panel |
61,060 |
51,074 |
$1.39M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
10,271 |
9,593 |
$1.05M |
| 70450 |
Computed tomography, head or brain; without contrast material |
8,660 |
7,373 |
$929K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
10,754 |
9,075 |
$783K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
4,343 |
3,832 |
$575K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,491 |
2,179 |
$472K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
16,461 |
15,589 |
$396K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
5,492 |
5,041 |
$308K |
| 87070 |
|
22,441 |
21,376 |
$245K |
| 87400 |
|
38,658 |
36,748 |
$217K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
2,845 |
2,728 |
$191K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
4,424 |
3,099 |
$174K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
3,202 |
2,667 |
$174K |
| 76830 |
Ultrasound, transvaginal |
2,429 |
2,214 |
$162K |
| 58670 |
|
189 |
163 |
$155K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,109 |
2,472 |
$147K |
| G0378 |
Hospital observation service, per hour |
12,223 |
6,560 |
$134K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
3,716 |
1,867 |
$129K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,873 |
1,605 |
$122K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,705 |
2,340 |
$122K |
| 59025 |
Fetal non-stress test |
1,056 |
698 |
$119K |
| 76801 |
|
2,572 |
2,233 |
$118K |
| 81025 |
|
24,015 |
22,118 |
$118K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,287 |
4,760 |
$118K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
19,574 |
18,583 |
$102K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,547 |
1,467 |
$100K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,563 |
2,345 |
$98K |
| 93975 |
|
5,627 |
4,862 |
$98K |
| 81001 |
|
28,121 |
24,985 |
$96K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
8,109 |
7,323 |
$89K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,540 |
1,290 |
$84K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,330 |
2,079 |
$83K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
16,098 |
13,416 |
$77K |
| J3490 |
Unclassified drugs |
1,654 |
1,257 |
$76K |
| 12011 |
|
1,106 |
1,010 |
$70K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,614 |
2,787 |
$70K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,973 |
4,540 |
$70K |
| 71045 |
Radiologic examination, chest; single view |
18,227 |
15,651 |
$69K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,236 |
1,967 |
$68K |
| 71046 |
Radiologic examination, chest; 2 views |
7,842 |
7,176 |
$67K |
| 12001 |
|
1,174 |
1,108 |
$66K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,223 |
854 |
$63K |
| 86850 |
|
3,139 |
2,749 |
$61K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,437 |
1,846 |
$60K |
| 93971 |
|
1,355 |
1,189 |
$52K |
| 85027 |
|
69,006 |
54,736 |
$51K |
| 10060 |
|
926 |
860 |
$49K |
| 74018 |
|
2,949 |
2,729 |
$49K |
| 87210 |
|
5,471 |
5,028 |
$49K |
| 72131 |
|
963 |
824 |
$48K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
804 |
724 |
$43K |
| 81003 |
|
9,252 |
8,407 |
$43K |
| 73130 |
|
2,492 |
2,249 |
$42K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
970 |
717 |
$41K |
| 93970 |
|
641 |
563 |
$38K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
34,597 |
28,932 |
$37K |
| 84702 |
|
6,320 |
5,002 |
$35K |
| 87430 |
|
26,495 |
25,311 |
$33K |
| 84112 |
|
749 |
651 |
$33K |
| 87420 |
|
7,435 |
7,131 |
$33K |
| A9270 |
Non-covered item or service |
15,278 |
3,327 |
$32K |
| 73630 |
|
3,222 |
2,954 |
$31K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
22,404 |
18,255 |
$30K |
| 73610 |
|
2,843 |
2,604 |
$30K |
| 84484 |
|
18,602 |
12,036 |
$29K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
21,699 |
17,453 |
$28K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
16,815 |
12,767 |
$27K |
| 73140 |
|
976 |
881 |
$27K |
| 73564 |
|
2,833 |
2,398 |
$27K |
| 73030 |
|
1,983 |
1,692 |
$26K |
| 70491 |
|
110 |
98 |
$26K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
248 |
194 |
$25K |
| 73110 |
|
1,730 |
1,557 |
$24K |
| 70486 |
|
526 |
480 |
$21K |
| G0383 |
Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
150 |
137 |
$21K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
600 |
537 |
$20K |
| 87040 |
|
5,275 |
3,782 |
$19K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
10,520 |
9,887 |
$19K |
| 12002 |
|
431 |
406 |
$18K |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
361 |
141 |
$18K |
| 76770 |
|
135 |
125 |
$17K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
12,816 |
10,314 |
$17K |
| 96376 |
|
4,571 |
2,562 |
$17K |
| 72110 |
|
552 |
481 |
$17K |
| 73090 |
|
926 |
836 |
$17K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
191 |
165 |
$15K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
7,193 |
4,324 |
$15K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,860 |
1,383 |
$14K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,087 |
1,836 |
$13K |
| J2704 |
Injection, propofol, 10 mg |
1,274 |
888 |
$13K |
| 86900 |
|
5,360 |
4,683 |
$12K |
| 84703 |
|
13,481 |
11,922 |
$12K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
4,352 |
4,090 |
$12K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,477 |
1,012 |
$12K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
6,859 |
3,565 |
$12K |
| 83880 |
|
4,831 |
4,001 |
$11K |
| 85610 |
|
9,143 |
7,550 |
$10K |
| 73070 |
|
651 |
572 |
$10K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
293 |
154 |
$8K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
12,693 |
9,352 |
$8K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,938 |
1,902 |
$8K |
| 85730 |
|
7,135 |
6,002 |
$8K |
| 71101 |
|
166 |
146 |
$8K |
| C1729 |
Catheter, drainage |
224 |
211 |
$7K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
7,111 |
5,718 |
$7K |
| 73590 |
|
965 |
843 |
$7K |
| 83735 |
|
11,913 |
8,992 |
$7K |
| 83605 |
|
4,237 |
3,452 |
$7K |
| 81002 |
|
8,677 |
8,157 |
$6K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
76 |
74 |
$6K |
| 76820 |
|
1,428 |
686 |
$5K |
| 95816 |
|
134 |
115 |
$5K |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,036 |
532 |
$5K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
4,356 |
4,095 |
$5K |
| 86901 |
|
5,352 |
4,667 |
$5K |
| 76857 |
|
380 |
355 |
$5K |
| S0028 |
Injection, famotidine, 20 mg |
3,285 |
2,836 |
$5K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
27 |
25 |
$4K |
| 93017 |
|
220 |
166 |
$4K |
| J1815 |
Injection, insulin, per 5 units |
2,183 |
916 |
$4K |
| 97163 |
|
422 |
313 |
$4K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,454 |
2,958 |
$4K |
| 85379 |
|
3,789 |
3,409 |
$3K |
| 72128 |
|
57 |
51 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,462 |
3,000 |
$3K |
| 87186 |
|
3,291 |
2,939 |
$3K |
| 84145 |
|
888 |
712 |
$3K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
114 |
100 |
$2K |
| 73080 |
|
134 |
123 |
$2K |
| 83690 |
|
15,008 |
13,092 |
$2K |
| C1769 |
Guide wire |
111 |
86 |
$2K |
| 80061 |
Lipid panel |
1,660 |
1,373 |
$2K |
| 29125 |
|
677 |
623 |
$2K |
| 70487 |
|
12 |
12 |
$2K |
| 36430 |
|
27 |
24 |
$2K |
| 73502 |
|
271 |
225 |
$2K |
| 88307 |
|
31 |
26 |
$2K |
| 80069 |
|
653 |
437 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,237 |
1,032 |
$2K |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,772 |
1,763 |
$2K |
| 86140 |
|
2,398 |
2,143 |
$2K |
| 86738 |
|
745 |
657 |
$2K |
| 00840 |
|
66 |
53 |
$1K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
217 |
130 |
$1K |
| 76870 |
|
146 |
132 |
$1K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
32 |
25 |
$1K |
| 88304 |
|
143 |
130 |
$1K |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
220 |
197 |
$1K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,475 |
1,273 |
$1K |
| J2060 |
Injection, lorazepam, 2 mg |
1,194 |
958 |
$1K |
| 76818 |
|
15 |
13 |
$1K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
418 |
384 |
$1K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
508 |
321 |
$1K |
| 87205 |
|
1,552 |
1,372 |
$962.02 |
| 29515 |
|
115 |
102 |
$911.07 |
| 73060 |
|
165 |
156 |
$884.66 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,979 |
2,561 |
$874.16 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
2,323 |
2,009 |
$857.40 |
| 82270 |
|
59 |
51 |
$853.07 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
14 |
12 |
$850.61 |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
27 |
24 |
$844.37 |
| 12013 |
|
12 |
12 |
$836.08 |
| 96368 |
|
13 |
13 |
$834.79 |
| 82570 |
|
528 |
469 |
$745.54 |
| 82731 |
|
12 |
12 |
$742.73 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,720 |
3,446 |
$731.92 |
| 73660 |
|
79 |
74 |
$672.83 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,748 |
2,207 |
$660.21 |
| 82550 |
|
1,635 |
1,321 |
$595.69 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,329 |
805 |
$556.50 |
| 82247 |
|
30 |
24 |
$494.81 |
| 99152 |
|
17 |
13 |
$489.36 |
| 73503 |
|
28 |
24 |
$483.60 |
| 84439 |
|
996 |
885 |
$470.32 |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
15 |
14 |
$465.48 |
| 85652 |
|
778 |
682 |
$448.62 |
| 73100 |
|
16 |
13 |
$410.00 |
| 86308 |
|
154 |
152 |
$403.48 |
| 84156 |
|
603 |
511 |
$393.78 |
| 84100 |
|
659 |
506 |
$380.30 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
202 |
158 |
$360.92 |
| J2791 |
Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu |
41 |
40 |
$327.52 |
| 90714 |
|
885 |
783 |
$316.62 |
| 85045 |
|
293 |
154 |
$296.35 |
| 86592 |
|
68 |
53 |
$293.53 |
| 71250 |
|
13 |
12 |
$287.52 |
| 85384 |
|
105 |
96 |
$278.65 |
| 72100 |
|
27 |
24 |
$237.25 |
| 73552 |
|
133 |
107 |
$212.52 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
125 |
105 |
$210.42 |
| J2785 |
Injection, regadenoson, 0.1 mg |
127 |
91 |
$168.10 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
205 |
176 |
$160.04 |
| 74019 |
|
102 |
99 |
$143.30 |
| 93880 |
|
22 |
14 |
$137.51 |
| 97116 |
|
25 |
18 |
$130.19 |
| 82803 |
|
120 |
93 |
$128.29 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
456 |
342 |
$120.14 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
37 |
33 |
$116.20 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
158 |
107 |
$75.88 |
| 90715 |
|
540 |
495 |
$73.52 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
138 |
119 |
$45.53 |
| 70360 |
|
27 |
26 |
$35.85 |
| 76821 |
|
15 |
13 |
$31.07 |
| 80076 |
|
58 |
50 |
$16.66 |
| 82248 |
|
84 |
64 |
$11.76 |
| 83615 |
|
197 |
172 |
$1.47 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
417 |
326 |
$0.00 |
| C1758 |
Catheter, ureteral |
83 |
79 |
$0.00 |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
116 |
89 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
274 |
248 |
$0.00 |
| 00851 |
|
202 |
160 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
208 |
138 |
$0.00 |
| Q0177 |
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
177 |
156 |
$0.00 |
| 84550 |
|
96 |
82 |
$0.00 |
| S5000 |
Prescription drug, generic |
48 |
47 |
$0.00 |
| 85014 |
|
14 |
12 |
$0.00 |
| 76827 |
|
25 |
25 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
43 |
31 |
$0.00 |
| J0456 |
Injection, azithromycin, 500 mg |
126 |
92 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
658 |
601 |
$0.00 |
| 88342 |
|
207 |
187 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
58 |
45 |
$0.00 |
| 73560 |
|
13 |
12 |
$0.00 |
| 82150 |
|
59 |
55 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
25 |
15 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
26 |
24 |
$0.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
37 |
28 |
$0.00 |
| 76825 |
|
25 |
25 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
20 |
12 |
$0.00 |